Published date: 12 February 2021

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 21 October 2020, 11:59pm

Contract summary

Industry

  • Vaccines - 33651600

Location of contract

United Kingdom

Value of contract

£1

Procurement reference

4681/10/2020

Published date

12 February 2021

Closing date

21 October 2020

Closing time

11:59pm

Contract start date

22 October 2020

Contract end date

31 December 2021

Contract type

Supply contract

Procedure type

Single tender action (below threshold)

A direct contract with a single supplier, without competition.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

Procurement of Novavax's vaccine candidate NVX-CoV2373, as intended for the prophylaxis and vaccination against SARS-CoV-2 in humans.

Note:

This notice corrects and supersedes a previous notice (see links section).

It does not represent a new arrangement or contract with the supplier.

More information

Links

Additional text

Information on contract value is being withheld due to commercial sensitivity under Regulation 50(6)(b) and (c) as the publication of the price may enable competitors to calculate cost per dose. This will (i) commercially prejudice the supplier in its ongoing negotiations with other national governments; (ii) commercially prejudice the contracting authority in its ongoing negotiations with other vaccine vendors and (iii) impact fair competition between vaccine vendors .

Contract end date is being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). The contract end date is variable based on production and delivery of the requirement. There are significant challenges to overcome and the end date may not be a true reflection, setting unrealistic expectation for the public and in the market. This information is also being withheld on due to commercial sensitivity under Regulation 50(6)(b) and (c) as there is significant competition to develop and bring to the market a successful vaccine. Provision of the contract term may provide valuable information to competitors that may impact negotiations or future competition in the market.
Sub-contractor details are being withheld on grounds that release of the information would be contrary to public interest under Regulation 50(6)(a). This information is very sensitive given potential for targeting and disruption of the activities at the facilities which would be contrary to public interest as these activities are critical to success and delivery of the requirement.

Award information

Awarded date

22 October 2020

Contract start date

22 October 2020

Contract end date

31 December 2021

Total value of contract

£1

This contract was awarded to 1 supplier.

Novavax Inc.

Address

21 Firstfield Road
Gaithersburg
20878

Reference

No reference - other

Value of contract

£1

Supplier is SME?

No

Supplier is VCSE?

No

Attachments

About the buyer

Address

1 Victoria Street
London
SW1H0ET
England

Email

VTFContracts@beis.gov.uk